World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
30848
World Ranking
11739
National Ranking
6021

Adam P. Dicker publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Adam P. Dicker sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 743 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Adam P. Dicker D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Adam P. Dicker sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Adam P. Dicker is affiliated with Thomas Jefferson University in the United States. Their research primarily spans the field of Medicine with a focus on several subfields including Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research, and Genetics.

The main topics addressed in their work include Radiomics and Machine Learning in Medical Imaging, Cancer Immunotherapy and Biomarkers, Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, Glioma Diagnosis and Treatment, Ferroptosis and cancer prognosis, and Lung Cancer Treatments and Mutations.

Frequent publication venues for Adam P. Dicker include the Journal of Clinical Oncology, where they have published 27 papers, the International Journal of Radiation Oncology*Biology*Physics with 17 publications, Neuro-Oncology with 13, JCO Clinical Cancer Informatics with 7, and bioRxiv (Cold Spring Harbor Laboratory) with 5 papers.

They have collaborated extensively with several co-authors, notably Michal Harel with 25 joint publications, Coren Lahav with 21, Adam E. Flanders with 20, Christos Davatzikos with 19, and Suyash Mohan also with 19 collaborative works.

Selected recent papers include:

  1. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer, 2020, JAMA Oncology
  2. Federated learning enables big data for rare cancer boundary detection, 2022, Nature Communications
  3. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019, 2020, Journal of Clinical Oncology
  4. NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma, 2022, Journal of Clinical Oncology
  5. Innovations in research and clinical care using patient-generated health data, 2020, CA A Cancer Journal for Clinicians

Best Publications

  • Managing toxicities associated with immune checkpoint inhibitors: Consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

    I. Puzanov;A. Diab;K. Abdallah;C. O. Bingham

  • American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

    Lowell E. Schnipper;Nancy E. Davidson;Dana S. Wollins;Courtney Tyne

  • Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

    Ryan Phillips;William Yue Shi;Matthew Deek;Noura Radwan

  • Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

    Lowell E. Schnipper;Nancy E. Davidson;Dana S. Wollins;Douglas W. Blayney

  • Microsurgical inguinal varicocelectomy with delivery of the testis: an artery and lymphatic sparing technique.

    Marc Goldstein;Bruce R. Gilbert;Adam P. Dicker;Jack Dwosh

  • Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.

    Peter Grimm;Ignace Billiet;David Bostwick;Adam P Dicker

  • Zebrafish: an emerging model system for human disease and drug discovery.

    G Kari;U Rodeck;A P Dicker

  • Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer

    James J. Farrell;Hany Elsaleh;Miguel Garcia;Raymond Lai

  • Dihydrofolate reductase as a therapeutic target.

    Barry I. Schweitzer;Adam P. Dicker;Joseph R. Bertino

  • Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.

    Phyllis Wachsberger;Randy Burd;Adam P. Dicker

  • Dual Roles of PARP-1 Promote Cancer Growth and Progression

    Matthew J. Schiewer;Jonathan F. Goodwin;Sumin Han;J. Chad Brenner

  • Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas

    Shannon E. Fogh;David W. Andrews;Jon Glass;Walter Curran

  • A hormone-DNA repair circuit governs the response to genotoxic insult

    Jonathan F. Goodwin;Matthew J. Schiewer;Jeffry L. Dean;Randy S. Schrecengost

  • Differentiation and definition of vascular-targeted therapies.

    Dietmar W. Siemann;Michael C. Bibby;Graham G. Dark;Adam P. Dicker

  • The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments.

    Agnieszka K. Witkiewicz;Karen E. Knudsen;Adam P. Dicker;Erik S. Knudsen

  • Radiotherapy Protocol Deviations and Clinical Outcomes: A Meta-analysis of Cooperative Group Clinical Trials

    Nitin Ohri;Xinglei Shen;Adam P. Dicker;Laura A. Doyle

  • Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)

    Derrick S. Grant;Torian L. Williams;Michael Zahaczewsky;Adam P. Dicker

  • The role of lineage plasticity in prostate cancer therapy resistance

    Himisha Beltran;Andrew Hruszkewycz;Howard I. Scher;Jeffrey Hildesheim

  • Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry : An analysis based on serial CT acquisition

    Frank M. Waterman;Ning Yue;Benjamin W. Corn;Adam P. Dicker

  • RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1

    John R Prensner;Shuang Zhao;Nicholas Erho;Matthew Schipper

Frequent Co-Authors

Leonard G. Gomella
Leonard G. Gomella Thomas Jefferson University
David W. Andrews
David W. Andrews Sunnybrook Health Science Centre
Edward M. Schaeffer
Edward M. Schaeffer Northwestern University
Karen E. Knudsen
Karen E. Knudsen Thomas Jefferson University
Bo Lu
Bo Lu The Ohio State University
Eric A. Klein
Eric A. Klein Cleveland Clinic
Ulrich Rodeck
Ulrich Rodeck Thomas Jefferson University
Walter J. Curran
Walter J. Curran Emory University
Stephen J. Freedland
Stephen J. Freedland Cedars-Sinai Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean attending traditional, in-person programs. There are a growing number of online degrees and certifications that can help launch or advance healthcare careers in a flexible way. For those interested in wellness, a bachelor's in nutrition online offers specialized knowledge in dietary science and prepares students for roles in nutrition counseling, public health, or food service management.

For individuals aiming at leadership roles in healthcare, many accredited mha programs are available online, providing the skills required for hospital administration and health policy management. Registered nurses looking to further their education without intensive clinical requirements might consider rn to bsn online without clinicals programs, which allow for flexibility without sacrificing quality.

For nurses seeking advanced practice roles, dnp programs online enable career progression into leadership, education, or specialized clinical practice. These diverse online pathways make healthcare education more accessible, helping students build rewarding careers in medicine and beyond.

Best Scientists Citing Adam P. Dicker

Trending Scientists

Recently Published Articles